Total dose needles are available in the 5 most commonly used sizes - orange (16 and 25mm), blue (25mm and 30mm), and green (40mm).
Please note that Total Dose needles fit best on the Nevershare 2ml syringe, and do NOT fit on:
* Terumo 1ml, , or 5ml syringes;
* The BD 2ml 'Emerald' syringe;
* Frontier (and some other) 2ml, 5ml, and 10ml syringes; or
* Syringes with a spike that goes into the tip of the syringe.
Click on the images or product names below for more information.
The adverse effects of corticosteroids in pediatric patients are similar to those in adults (see ADVERSE REACTIONS ). Like adults, pediatric patients should be carefully observed with frequent measurements of blood pressure, weight, height, intraocular pressure, and clinical evaluation for the presence of infection, psychosocial disturbances, thromboembolism, peptic ulcers, cataracts, and osteoporosis. Pediatric patients who are treated with corticosteroids by any route, including systemically administered corticosteroids, may experience a decrease in their growth velocity. This negative impact of corticosteroids on growth has been observed at low systemic doses and in the absence of laboratory evidence of HPA axis suppression (., cosyntropen stimulation and basal cortisol plasma levels). Growth velocity may therefore be a more sensitive indicator of systemic corticosteroid exposure in pediatric patients treated with corticosteroids should be monitored, and the potential growth effects of prolonged treatment should be weighed against clinical benefits obtained and the availability of treatment alternatives. In order to minimize the potential growth effects of corticosteroids, pediatric patients should be titrated to the lowest effective dose.